AM

Arun Mahadeo Nawade

Active Director Designated Partner DIN 11108858
DIN 11108858 First appointment May 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Arun Mahadeo Nawade

Data last updated:

Arun Mahadeo Nawade is a Designated Partner at Elefant Lifecare Llp (since 2026) and Director at Ozonext Pharmaceutical Private Limited (since 2025).

DIN 11108858
Primary Designation Designated Partner
First Appointment 15 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner24 Jun 20262026Active
Director15 May 20252025Active

Directorship timeline

Open interactive timeline →
Ozonext Pharmaceutical Private Limited
Elefant Lifecare Llp
Premium access

Shareholding and investment profile for Arun Mahadeo Nawade

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arun Mahadeo Nawade

Arun Mahadeo Nawade currently holds 2 directorships: Elefant Lifecare Llp (Designated Partner, since 24 Jun 2026); Ozonext Pharmaceutical Private Limited (Director, since 15 May 2025).

Arun Mahadeo Nawade was first appointed on 15 May 2025 as Director at Ozonext Pharmaceutical Private Limited. The most recent appointment on record is 24 Jun 2026 at Elefant Lifecare Llp.

The current boards of Arun Mahadeo Nawade's companies include Arjun Shah (Elefant Lifecare Llp), Ganesh Dattatray Agawane (Elefant Lifecare Llp), Tanvi Kanishka Davda (Elefant Lifecare Llp), Mahesh Raosaheb Shelke (Ozonext Pharmaceutical Private Limited), Shriram Raghunath Nawade (Ozonext Pharmaceutical Private Limited), Vijeta Kishor Bagade (Ozonext Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available